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Case report
A 66-year-old non-smoker Chinese female was 
hospitalised after her first episode of haemoptysis 
(approximate volume, 100 mL) in February 2012. She 
reported being in good health, except for an episode 
of right lower lobe pneumonia about 6 months before 
presentation, which was treated with antibiotics. 
Despite radiological recovery, she complained of 
occasional dry cough, malaise, and weight loss of 
approximately 10 pounds in the subsequent months. 
 At admission, she was afebrile, without 
dyspnoea, and with unremarkable physical findings. 
Apart from mild anaemia (haemoglobin, 107 g/L) 
and slightly elevated erythrocyte sedimentation 
rate of 47 mm/h, other laboratory tests including 
white cell and platelet counts, C-reactive protein, 
coagulation profile, and liver and renal function 
tests were within normal limits. Culture, acid-
fast staining, and cytological examination of the 
sputum did not reveal any abnormality. Radiological 
examination of the chest revealed a peripheral 
shadow measuring 1.5 cm in diameter in the right 
middle zone. Thoracic computed tomography (CT) 
revealed a huge contrast-enhancing mass with low, 
non-homogeneous attenuation filling the right 
pulmonary artery (PA), extending up to the right 
A B S T R A C T 
Pulmonary artery sarcoma is a rare disease with poor 
prognosis that has not been reported in Hong Kong. 
Its clinical and radiological presentation frequently 
mimics pulmonary embolism. Diagnosis is usually 
delayed until surgery, which is the treatment option 
that provides the best survival. Endobronchial 
ultrasound-guided transbronchial needle aspiration 
is an effective non-surgical technique for lymph node 
staging of lung cancer and diagnosis of mediastinal 
lesions via bronchoscopy. Here we discuss a case 
of pulmonary artery sarcoma diagnosed by this 
method, the second one in the literature, which 
serves to illustrate its potential use for early and 
minimally invasive diagnosis of the condition. 
Although such aspiration is a safe procedure, tissue 
sampling of extravascular extensions is advisable 
wherever possible. 
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CASE REPORT
upper and lower segmental pulmonary arteries, as 
well as into the mediastinum. Patchy foci were also 
noted in the pulmonary trunk (Fig 1). Peripheral 
soft tissue densities were noted in the right middle 
lobe, which may have been either infarcts or 
tumour deposits. Bronchoscopy and endobronchial 
ultrasound-guided transbronchial needle aspiration 
(EBUS-TBNA) were performed to examine the 
airways and to obtain histological samples from 
the mediastinal extension of the mass. No bleeding 
source or significant endobronchial lesions were 
identified during bronchoscopy. A heterogeneous 
mass with distinct margins extending from the lower 
end of trachea to the right hilar regions along the right 
main bronchus was revealed by EBUS. Endobronchial 
ultrasound-guided transbronchial needle aspiration 
of the mass was performed at the lower end of 
trachea (Fig 2a). Histological examination revealed 
tumour fragments with spindle cells lying in myxoid 
stroma with no definite differentiation (Fig 2b). 
Immunohistochemistry revealed strongly positive 
smooth muscle actin expression, while CD-31, 
EMA, CK, calretinin, and S-100 were all negative. 
These findings were consistent with a diagnosis of 
pulmonary artery sarcoma (PAS). Echocardiogram 
revealed heterogeneous masses inside the main 
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陳偉文、朱彥瑤、林康琪、柯永馨、張靄怡、關鼎樂、
梁國璋、羅偉霖	
肺動脈肉瘤是一種罕見及存活率低的腫瘤，在香港未曾有病例報告。
此腫瘤的表現多被誤以為是肺血管栓塞，故此診斷和治療通常會較
遲。手術切除除了是最有效的治療方法，亦經常是提供確診的唯一機
會。支氣管鏡超聲波引導針吸活檢術（EBUS-TBNA）在診斷肺癌縱
膈淋巴轉移和其他縱膈病變的作用已被確認。本文報告以上述方法
治療肺動脈肉瘤的病例，為醫學文獻至今的第二宗相關報告，以說明
EBUS-TBNA有助肺動脈肉瘤早期和微創診斷的潛在能力。儘管它是
一個較安全的診斷方法，但從血管壁外的伸延部份去抽取樣本會是較
安全的做法。
支氣管鏡超聲波引導針吸活檢術診斷 
肺動脈肉瘤
pulmonary trunk, and between the aorta and the 
anterior aspect of left atrium, with no evidence of 
valvular dysfunction or pulmonary hypertension. 
FIG 1.  Thoracic computed tomography revealing a contrast-
enhancing mass (A) with low non-homogeneous attenuation 
filling the right pulmonary artery with extension into the 
mediastinum.  Another mass was also found in the pulmonary 
trunk (B)
Due to the presence of extensive disease and central 
location of the tumour, aggressive surgery was not 
considered appropriate by cardiothoracic surgeons. 
The patient declined palliative chemotherapy or 
radiotherapy and defaulted from follow-up.
Discussion
Pulmonary artery sarcoma is a rare condition that 
was first reported in 1923 from an autopsy.1 Apart 
from a few case series and reviews,2-6 most cases were 
only isolated case reports. Although it is sometimes 
divided into intimal and mural types, and further 
histological subtypes, the adherent nature of the 
tumour and the frequent lack of tissue differentiation 
sometimes do not allow such classifications, such as 
in our patient. As both the clinical and radiological 
features can resemble closely that of pulmonary 
embolism (PE), some reported cases were initially 
treated with anticoagulation therapy but without 
response.3,4 A definite diagnosis is usually delayed 
and made either at autopsy or intra-operatively 
with frozen sections.5 While dyspnoea, cough, 
and chest pain are the commonest presenting 
symptoms,2-5 haemoptysis has also been reported.3,7 
Lung involvement is commonly found,3,4 although 
the lung lesion in our patient could represent either 
tumour deposit or infarct, and both could have led 
to haemoptysis. On CT scan, the characteristics of 
PAS often mimic PE. Other features that support a 
diagnosis of PAS include a low-attenuation defect 
filling the whole lumen of main or proximal PA and 
extravascular extension,6 both of which were present 
in our patient. Considering the CT scan findings, 
along with the absence of clinical features and risk 
factors of vascular thrombosis, malignancy was 
suspected in our patient. Apart from CT scan, both 
magnetic resonance imaging (MRI; with gadolinium 
A
B
FIG 2.  (a) An ultrasonographic view of endobronchial 
ultrasound-guided transbronchial needle aspiration (TBNA) 
of a heterogeneous mass at the lower end of trachea (A: 
22G TBNA needle; B: outer boundary of the tumour mass). 
(b) Spindle cell proliferation in myxoid stroma; tumour cells 
show mild nuclear pleomorphism (H&E, x 200)
A
B
(a)
(b)
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contrast enhancement)4 and fluorodeoxyglucose–
positron emission tomography (FDG-PET)7 have 
been described as useful for the diagnosis of PAS. 
Imaging like CT and MRI may have enabled us to 
determine the exact nature of peripheral lung lesion 
in our patient.
 The prognosis of PAS is poor, with a median 
survival of 1.5 months without any treatment.2 If 
possible, radical resection of the tumour should 
be considered since median survival has been 
demonstrated to be significantly better with 
this option (36.5 ± 20.2 months) than that with 
incomplete resection such as tumour debulking 
and thromboendarterectomy (median survival, 
11 ± 3 months).4 Radical resections are usually 
major operations that might involve extensive 
resections and subsequent reconstructions and/
or prosthetic replacement of PA, pneumonectomy 
or thromboendarterectomy, and often requiring 
cardiopulmonary bypass.4,5 Multimodality treatment 
including neoadjuvant or adjuvant chemotherapy 
and radiation, together with surgery, might further 
improve survival.3,4 Owing to the rarity of PAS, 
currently there are no prospective data to guide 
the best management practices for PAS. Despite 
the apparent prognostic superiority of curative 
resection, an adequate cardiopulmonary reserve 
for the major surgery and the absence of extensive 
disease that precludes radical resection would be 
necessary. In view of the extensive disease, radical 
tumour resection was not considered in our patient. 
A definite diagnosis at an early stage would improve 
the chance of survival of PAS patients. However, 
in the past, such an opportunity was usually not 
available unless a patient underwent surgery.
 Endobronchial ultrasound-guided trans-
bronchial needle aspiration is a minimally invasive 
diagnostic procedure. The efficacy and safety of 
EBUS-TBNA, via the bronchoscopic route, in 
mediastinal and hilar lymph node staging of lung 
cancer have been well documented, with high 
sensitivity, specificity, and diagnostic accuracy of 
92.3%, 100% and 98%, respectively.8 This treatment 
modality can offer a more cost-effective and less 
invasive diagnostic option than mediastinoscopy.9 
It is also useful for diagnosing central pulmonary 
lesions adjacent to the bronchus10 and non-malignant 
conditions.11 Performed in an endoscopic suite, 
the procedure involves using a special endoscopic 
instrument incorporating a 7.5-MHz curvilinear 
ultrasonic transducer at the tip of a flexible 
bronchoscope, which allows needle aspiration of 
target lesions under real-time ultrasound guidance 
via a 22-gauge needle. The procedure is very safe 
and can be performed under local anaesthesia and 
conscious sedation.8-11 Our case is the second report 
in medical literature which illustrates the potential 
applicability of EBUS-TBNA in a histological 
diagnosis for PAS through a non-surgical route. In 
contrast to our case, in the first report describing 
two patients in literature, the TBNA involved 
puncturing of the pulmonary arterial wall in one of 
the patients undergoing the procedure.12 Although 
PA puncture in EBUS-TBNA has been reported to 
be safe,13 self-limiting intramural haematoma and 
haemopneumomediastinum have been described 
after an accidental EBUS-TBNA puncture,14 and so, 
the safety of EBUS-TBNA in the routine differential 
diagnosis of PAS and pulmonary thromboembolism 
have been doubted.15 In contrast, our patient had 
suspicious radiological features of PAS and absence 
of clinical features and risks for PE. We believe 
using EBUS-TBNA to approach extravascular 
extension of the lesion in such patients offers a 
relatively non-invasive means for early diagnosis of 
PAS. However, the safety of PA punctures in EBUS-
TBNA needs to be clarified in large studies. It must 
be remembered that performing EBUS-TBNA in 
patients with acute PE and pulmonary hypertension 
may be associated with a high risk of complications 
such as respiratory distress and bleeding.15 Thus, the 
routine use of EBUS-TBNA as a tool to distinguish 
PE from the rarer PAS is not encouraged. While MRI 
or FDG-PET may be considered before performing 
invasive diagnostic investigations,4 the present 
report suggests that EBUS-TBNA can potentially 
provide clinicians a diagnostic alternative to surgical 
exploration for patients suspected of having PAS.
Conclusion
Pulmonary artery sarcoma is a rare disease with 
poor prognosis, which is often diagnosed late and 
frequently mimics PE. Endobronchial ultrasound-
guided transbronchial needle aspiration may be a 
safe and easy option for the early diagnosis of the 
condition. Extravascular extension of the lesion on 
thoracic CT provides a diagnostic clue for PAS, and 
also offers a safe approach for performing EBUS-
TBNA.
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